.png)
Agenzia Italiana del Farmaco
home
Highlights
-
15 Jul 2025
Press releases
AIFA and Istituto Poligrafico e Zecca dello Stato renew their cooperation
Among the objectives of the agreement are to ensure the continuity and efficiency of “TrovaNormeFarmaco”.
-
14 Jul 2025
Press releases
AIFA redefines the criteria for awarding the "innovativeness status" to medicines
Possible fast track for companies investing in preclinical and clinical research in Italy. Immediate access to the Innovativeness Fund for reserve antibiotics used against multi-resistant germs.
-
10 Jul 2025
Press releases
AIFA hosts delegation of the Greek Ministry of Health to share experiences and best practices on HTA
Representatives of the European Commission and WHO Europe were also present.
-
09 Jul 2025
Press releases
AIFA Board of Directors approves the reimbursability of 7 medicines
A new medicine for moderate to severe ulcerative colitis and new medicine indications for multiple sclerosis and cystic fibrosis are some of the treatments that will be reimbursed by the National Health Service (SSN).
News
16 Jul 2025
Safety of medicinal products
Direct communication with healthcare professionals on risperidone-containing medicines
15 Jul 2025
Transparency Lists
AIFA updates the Transparency Lists
11 Jul 2025
Safety of medicinal products
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 7-10 July 2025
09 Jul 2025
Monitoring pharmaceutical expenditure
Biosimilar medicines in Italy: AIFA reports updated
08 Jul 2025
Inspections and authorisations
Annual list of manufacturing sites authorized/registered for production/importation of active substances updated to June 30, 2025
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
